A 'The Office' spinoff, 'The Paper,' premieres on Peacock in 2025, following a struggling Ohio newspaper with an optimistic new editor-in-chief and an unconventional newsroom staff.
Charity rowing team mistaken for 'illegal migrants' by MP, leading to multiple interventions, but crew uses attention to highlight fundraising for motor neurone disease research.
Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise despite higher R&D expenses and a decline in operating margin.
A 'The Office' spinoff, 'The Paper,' premieres on Peacock in 2025, following a struggling Ohio newspaper with an optimistic new editor-in-chief and an unconventional newsroom staff.
Charity rowing team mistaken for 'illegal migrants' by MP, leading to multiple interventions, but crew uses attention to highlight fundraising for motor neurone disease research.
Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise despite higher R&D expenses and a decline in operating margin.